Latest News about TCRR

Recent news which mentions TCRR

< Previous 1 2 Next >

TCR2 Therapeutics Shares Jump After Additional Reponses in Ovarian Cancer, Mesothelioma

September 28, 2022

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

September 28, 2022

12 Health Care Stocks Moving In Tuesday's After-Market Session

September 27, 2022

Stocks That Hit 52-Week Lows On Thursday

May 26, 2022

Stocks That Hit 52-Week Lows On Tuesday

April 19, 2022

10 Biggest Price Target Changes For Wednesday

March 23, 2022

12 Health Care Stocks Moving In Tuesday's Intraday Session

March 22, 2022

43 Stocks Moving In Tuesday's Mid-Day Session

March 22, 2022

Stocks That Hit 52-Week Lows On Monday

March 14, 2022

Stocks That Hit 52-Week Lows On Tuesday

February 22, 2022

Stocks That Hit 52-Week Lows On Friday

February 18, 2022

Stocks That Hit 52-Week Lows On Thursday

February 17, 2022

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

January 25, 2022

20 Stocks Moving in Tuesday's Pre-Market Session

January 25, 2022

12 Health Care Stocks Moving In Friday's Pre-Market Session

January 21, 2022

12 Health Care Stocks Moving In Thursday's After-Market Session

January 20, 2022

Stocks That Hit 52-Week Lows On Wednesday

January 19, 2022

Stocks That Hit 52-Week Lows On Friday

January 14, 2022

10 Biggest Price Target Changes For Thursday

January 13, 2022

Stocks That Hit 52-Week Lows On Thursday

January 06, 2022

Analyst Ratings For TCR2 Therapeutics

October 21, 2021

10 Biggest Price Target Changes For Thursday

October 21, 2021

12 Health Care Stocks Moving In Wednesday's Intraday Session

October 20, 2021

12 Health Care Stocks Moving In Thursday's Pre-Market Session

October 14, 2021

The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs

October 08, 2021

The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results

October 07, 2021

The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout

October 05, 2021

The Daily Biotech Pulse: Merck Rallies On Antiviral Pill Data, Gilead Files For Yescarta Label Expansion, Exscientia IPO

October 01, 2021

The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody Cocktail Data, Takeda In-Licenses Huntington's Disease Drug

September 30, 2021

The Daily Biotech Pulse: AbbVie's Migraine Drug OK'd By FDA, Amicus Spins Off Gene Therapy Business, Geovax In-Licenses Cancer Drug

September 29, 2021

< Previous 1 2 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.